Select Publications
Journal articles
2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815
,2017, 'EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', NEPHROLOGY DIALYSIS TRANSPLANTATION, 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', Nephrology Dialysis Transplantation, 32, pp. iii264 - iii265, http://dx.doi.org/10.1093/ndt/gfx149.sp427
,2017, 'SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', Nephrology Dialysis Transplantation, 32, pp. iii294 - iii294, http://dx.doi.org/10.1093/ndt/gfx151.sp493
,2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial', Nieren- und Hochdruckkrankheiten, 46, pp. 172 - 173
,2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2
,2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis a randomized clinical trial', JAMA Internal Medicine, 177, pp. 184 - 193, http://dx.doi.org/10.1001/jamainternmed.2016.8029
,2017, 'Association of socio-economic position with technique failure and mortality in australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 37, pp. 397 - 406, http://dx.doi.org/10.3747/pdi.2016.00209
,2017, 'Carvedilol and cardiac biomarkers in dialysis patients: Secondary analysis of a randomized controlled trial', Kidney and Blood Pressure Research, 42, pp. 1033 - 1044, http://dx.doi.org/10.1159/000485589
,2017, 'Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - A population cohort study', Oncotarget, 8, pp. 77771 - 77782, http://dx.doi.org/10.18632/oncotarget.20781
,2016, 'Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure', Peritoneal Dialysis International, 36, pp. 623 - 630, http://dx.doi.org/10.3747/pdi.2015.00218
,2016, 'Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients', Clinical Journal of the American Society of Nephrology, 11, pp. 1845 - 1855, http://dx.doi.org/10.2215/CJN.00190116
,2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418
,2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146
,2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269
,2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA - Journal of the American Medical Association, 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400
,2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156
,2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029
,2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629
,2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573
,2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022
,2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), 355, http://dx.doi.org/10.1136/bmj.i5599
,2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014
,2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27
,2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206
,2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815
,2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, 2, http://dx.doi.org/10.1186/s40697-015-0066-5
,2015, 'Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 35, pp. 450 - 459, http://dx.doi.org/10.3747/pdi.2013.00004
,2015, 'The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: The updated final trial protocol and rationale of post-initiation trial modifications', BMC Nephrology, 16, http://dx.doi.org/10.1186/s12882-015-0089-2
,2015, 'A nephrology guide to reading and using systematic reviews of randomized trials', Nephrology Dialysis Transplantation, 30, pp. 878 - 884, http://dx.doi.org/10.1093/ndt/gfu222
,2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362
,2015, 'The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 35, pp. 222 - 228, http://dx.doi.org/10.3747/pdi.2013.00156
,2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020
,2015, 'Daily home hemodialysis: Balancing cardiovascular benefits with infectious harms', American Journal of Kidney Diseases, 65, pp. 6 - 8, http://dx.doi.org/10.1053/j.ajkd.2014.08.012
,2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews
,2014, 'The association between body mass index and mortality in incident dialysis patients', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0114897
,2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254
,2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050
,2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, 19, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378
,2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', The Lancet Infectious Diseases, 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2
,2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, 3
,2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature reviews. Nephrology, 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3
,2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391
,